The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of common stock in Pacific Biosciences of California, Inc. as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC each reported aggregate beneficial ownership of 23,515,935.71 shares of Pacific Biosciences common stock.
  • Percent of class: The reported holdings represent 7.6% of the outstanding class of common stock, par value $0.001 per share (CUSIP 69404D108).
  • Shared voting power: Both reporting persons disclosed shared voting power over 23,515,629.71 shares, with sole voting power of 0.00 shares.
  • Shared dispositive power: Both reporting persons disclosed shared dispositive power over 23,515,935.71 shares, with sole dispositive power of 0.00 shares.
  • Third-party interest noted: Silver Brick Management Pte Ltd is identified in Item 6 as a person known to have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities.
  • Event date: The date of the event requiring this filing is stated as September 30, 2026, with the statement signed on October 8, 2026.

Goldman Sachs Discloses 23.5 Million Shares in Pacific Biosciences as of September 30, 2026

According to the Schedule 13G filed jointly by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, the two reporting persons each reported aggregate beneficial ownership of 23,515,935.71 shares of Pacific Biosciences of California, Inc. common stock. The filing states that this represents 7.6% of the class. The Goldman Sachs Group, Inc. is organized in Delaware and classified as a parent holding company (HC, CO), while Goldman Sachs & Co. LLC is organized in New York and classified as a broker-dealer, investment adviser, and other (BD, OO, IA). Both entities share the same principal business address at 200 West Street, New York, NY 10282.

The filing discloses that neither reporting person holds sole voting or sole dispositive power over any shares. Shared voting power is reported at 23,515,629.71 shares for both entities, and shared dispositive power at 23,515,935.71 shares each. As explained in Exhibit 99.2, the securities reported by The Goldman Sachs Group, Inc. as parent holding company are owned, or may be deemed beneficially owned, by Goldman Sachs & Co. LLC, described in the filing as "a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940."

The filing further states, in accordance with SEC Release No. 34-39538, that the disclosure reflects securities beneficially owned by certain operating units collectively referred to as the "Goldman Sachs Reporting Units," and that the filing does not reflect securities, if any, beneficially owned by operating units of GSG whose ownership is disaggregated from that of the Goldman Sachs Reporting Units under the Release. Item 6 identifies Silver Brick Management Pte Ltd as a person known to have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities. The statement was signed by Ameen Soetan as attorney-in-fact for both entities on October 8, 2026.

What Was Disclosed

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC jointly disclosed beneficial ownership of 23,515,935.71 shares, equaling 7.6%, of Pacific Biosciences of California, Inc. common stock as of September 30, 2026, with no sole voting or dispositive power reported by either party.